LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 17.28 | 27.76 | 1052 | 838 | 1.2543 | 1.0943 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 17.28 | 27.76 | 1118 | 838 | 1.3330 | 1.1204 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 18.98 | 27.76 | 211 | 941 | 0.2242 | 0.4903 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 18.98 | 27.76 | 930 | 941 | 0.9882 | 0.9953 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 18.98 | 27.76 | 1088 | 941 | 1.1560 | 1.0579 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 18.98 | 27.76 | 1135 | 941 | 1.2060 | 1.0751 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 20.68 | 27.76 | 677 | 1119 | 0.6050 | 0.8202 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 20.68 | 27.76 | 992 | 1119 | 0.8865 | 0.9553 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 20.68 | 27.76 | 1149 | 1119 | 1.0268 | 1.0099 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 20.68 | 27.76 | 1208 | 1119 | 1.0795 | 1.0289 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 22.39 | 27.76 | 912 | 1305 | 0.6985 | 0.8749 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 22.39 | 27.76 | 1035 | 1305 | 0.7927 | 0.9181 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 22.39 | 27.76 | 1226 | 1305 | 0.9390 | 0.9775 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 22.39 | 27.76 | 1254 | 1305 | 0.9604 | 0.9855 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 24.09 | 27.76 | 977 | 1461 | 0.6684 | 0.8640 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 24.09 | 27.76 | 1083 | 1461 | 0.7410 | 0.8978 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 24.09 | 27.76 | 1295 | 1461 | 0.8860 | 0.9581 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 24.09 | 27.76 | 1336 | 1461 | 0.9140 | 0.9688 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 25.79 | 27.76 | 1067 | 1605 | 0.6647 | 0.8652 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 25.79 | 27.76 | 1153 | 1605 | 0.7183 | 0.8901 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 25.79 | 27.76 | 1357 | 1605 | 0.8454 | 0.9434 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 25.79 | 27.76 | 1392 | 1605 | 0.8672 | 0.9519 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 27.49 | 27.76 | 1123 | 1723 | 0.6517 | 0.8613 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 27.49 | 27.76 | 1201 | 1723 | 0.6970 | 0.8824 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 27.49 | 27.76 | 1381 | 1723 | 0.8014 | 0.9270 | MN20160318_Q01 | M06 |